White Paper Download: Getting Ready for a Bio-Pharma Partnering Deal

Linda Pullan | Pullan Consulting

In order to thrive, biotechnology firms must successfully license their discoveries or, as is increasingly more common these days, partner with large pharmaceutical firms to develop their product. The right time to seek a partnering or licensing agreement and who to seek it with can be a daunting task, but breaking it down into the major elements that need to be considered will help you to develop an actionable plan. 


This complimentary white paper provides actionable advice for Biotech business development leaders  on how to get ready for a partnering deal:


  • Background on transactional readiness
  • Should you partner now?
  • Process to a deal
  • Negotiations prep
  • Negotiations
  • Term Sheets
  • On to the full agreement

  •  

To download Getting Ready for a Bio-Pharma Partnering Deal, please fill out the form below:

About the Author

Linda Pullan

Linda M. Pullan, Ph.D. offers biotech and pharmaceutical companies consulting in all aspects of partnering through Pullan Consulting (www.pullanconsulting.com). Linda has a Ph.D. in Biochemistry and a B.S. in Chemistry. Linda has more than 20 years of drug industry experience, beginning in drug discovery at Monsanto/Searle/now Pfizer and ICI/Zeneca/now AstraZeneca. After doing licensing at what is now AstraZeneca, Dr. Pullan continued as head of oncology and hematology licensing for Amgen. She then joined Kosan Biosciences as VP of Business Development and experienced all the tasks of out-licensing and business development in a small company. For several years, she has been providing companies help in identification, evaluation, valuation, negotiation and strategy for partnering in or out. She has an extensive deal sheet ranging from company acquisitions to Phase III compounds and from preclinical candidates to technologies, with both in- and out-licensing. She writes a free monthly newsletter Pullan's Pieces, with tidbits of science and business for about 3,600 readers. Interested readers may sign up by sending an email to lpullan@msn.com.